Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3021691	b-plas-p	— (—)	55	126	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Fever of other and unknown origin

19.32

30.32

2.5

2.3

—

Intestinal infectious diseases

6.23

12.97

2.3

—

Persons with potential health hazards related to communicable diseases

7.94

8.77

2.3

2.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

5.82

8.64

2.2

2.5

—

Contact with and exposure to communicable diseases

7.83

7.94

2.2

2.4

—

General symptoms and signs

4.58

7.02

2.5

2.3

—

Explicit Sepsis

6.39

5.98

3.0

2.3

—

L04AX Other immunosuppressants

5.00

5.25

1.9

2.5

—

Second line medication for Crohn's disease

4.78

5.00

1.9

2.7

—

ILD medications: immunosuppressive drugs

4.11

4.53

2.3

2.6

—

Other septicaemia

7.14

3.80

3.4

2.1

—

Certain infectious and parasitic diseases

3.69

3.74

2.6

2.1

—

IBD patients in KELA-register

7.78

3.55

2.3

2.9

—

Inflammatory bowel disease, strict (require KELA)

7.78

3.55

2.3

2.9

—

Septicaemia

5.92

3.39

3.4

2.1

—

Inflammatory bowel disease

7.00

3.36

2.3

2.7

—

Exposure to unspecified factor

2.91

3.31

2.2

2.3

—

Persons encountering health services in other circumstances

5.33

3.18

1.8

2.5

—

Other bacterial diseases

3.10

3.08

2.8

2.1

—

Ectopic pregnancy

10.01

2.98

2.2

2.6

—

Renal tubulo-interstitial diseases

3.07

2.88

2.9

2.1

—

Bronchitis

2.66

2.74

2.0

2.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

7.15

2.55

2.4

2.7

—

Ulcerative colitis (strict definition, require KELA)

7.15

2.55

2.4

2.7

—

Dysphagia

7.14

2.55

1.6

1.7

—

5-aminosalicylic acid

7.14

2.55

2.4

3.0

—

Cystitis

2.74

2.47

1.8

2.3

—

Pneumonia, organism unspecified

2.95

2.46

2.7

2.1

—

Other diseases of urinary system

2.63

2.41

1.9

2.5

—

Diseases of liver

5.00

2.40

2.7

1.9

—

Asthma-related pneumonia

4.99

2.40

2.8

1.9

—

Asthma-related pneumonia or sepsis

4.99

2.40

2.8

1.9

—

Asthma, hospital admissions 3, pneumonia

4.99

2.40

2.8

1.9

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

6.25

2.37

2.4

2.6

—

Peritonsillar abscess

6.25

2.37

1.4

2.4

—

COPD/asthma related infections

2.71

2.29

2.4

2.0

—

COPD/asthma/ILD related infections

2.71

2.29

2.4

2.0

—

Acute tubulo-interstitial nephritis

3.19

2.25

2.8

2.3

—

Other/unspecified dorsalgia

3.87

2.24

2.7

—

Malaise and fatigue

5.95

2.23

2.6

3.0

—

Ulcerative colitis

5.56

2.21

2.4

2.7

—

Influenza and pneumonia

2.42

2.18

2.9

2.0

—

ILD medications

2.35

2.11

2.1

2.4

—

Dental caries 1 and operation codes

2.82

2.09

2.3

—

Sleep apnoea, including avohilmo

2.64

2.01

2.1

2.3

—

Symptoms and signs involving the urinary system

2.90

2.00

2.7

2.3

—

2.45

1.97

2.2

2.3

—

Noninfective enteritis and colitis

3.33

1.96

2.3

2.4

—

Autoimmune diseases related-to ILD

2.48

1.93

2.1

2.4

—

Abnormalities of heart beat

4.51

1.92

2.4

2.7

—

Other disorders of urethra and urinary system

2.81

1.92

1.9

2.4

—

Other symptoms and signs involving the nervous and musculoskeletal systems

3.53

1.83

2.5

2.6

—

Sleep disorders (combined)

2.38

1.83

1.9

2.5

—

Covid-19 confirmed case

4.17

1.82

2.6

2.5

—

Sleep apnoea

2.61

1.82

1.9

2.2

—

Disorders of sclera, cornea, iris and ciliary body

3.04

1.79

2.1

2.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.61

1.78

3.1

2.0

—

2.61

1.78

3.1

2.0

—

Inflammatory bowel disease treatment related agents

2.21

1.77

1.9

2.5

—

Diseases of the digestive system

3.33

1.74

2.3

2.6

—

All pneumoniae

2.30

1.73

3.2

2.0

—

Benzodiazepine use

2.25

1.66

2.3

2.4

—

Acute upper respiratory infections of multiple and unspecified sites

2.42

1.63

2.0

2.4

—

Asthma, hospital admission 2, infections

2.75

1.61

2.6

2.5

—

Asthma-related infections

2.75

1.61

2.6

2.5

—

Urticaria

3.57

1.61

2.6

2.2

—

Codeine or tramadol medication

2.18

1.60

2.1

2.4

—

Acute upper respiratory infections

2.21

1.57

2.3

—

Atrial fibrillation and flutter

3.63

1.53

2.4

2.2

—

Other arthritis (FG)

3.33

1.52

1.8

2.7

—

Hernia of abdominal wall

3.33

1.52

2.8

2.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.58

1.50

2.7

2.3

—

Oral corticosteroids

2.14

1.45

1.8

2.5

—

Codeine

2.24

1.44

2.0

2.1

—

Pneumonias (Asthma/COPD co-morbidities)

2.18

1.43

3.1

2.1

—

Dorsalgia

2.07

1.43

2.4

—

Gestational diabetes (for exclusion)

2.83

1.42

2.0

2.5

—

Other acute lower respiratory infections

2.73

1.42

1.8

2.6

—

Unspecified fall

2.71

1.42

2.2

2.4

—

Examination and observation for other reasons

0.00

1.37

0.0

2.3

—

Glucosamine medication

3.07

1.37

1.8

2.1

—

Bacterial infection, other or unspecified

3.01

1.37

2.6

2.2

—

Obesity due to excess calories

2.61

1.36

2.2

—

Codes for special purposes

2.61

1.36

2.7

2.4

—

Provisional assignment of new diseases of uncertain etiology

2.61

1.36

2.7

2.4

—

Injuries to the knee and lower leg

1.95

1.36

2.3

—

Urticaria and erythema

2.94

1.36

2.6

2.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.05

1.32

2.0

2.4

—

First line medication for Crohn's disease

1.97

1.28

2.2

2.4

—

Opioids

2.03

1.26

2.1

—

Asthma (only as main-diagnosis)

2.30

1.25

2.4

2.2

—

Fall on same level involving ice and snow

2.40

1.24

3.3

2.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.61

1.20

3.2

2.5

—

Concussion

2.36

1.20

1.8

2.6

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.31

1.18

2.5

2.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.31

1.18

2.8

2.1

—

Falls/tendency to fall

1.91

1.17

2.4

2.2

—

Venous thromboembolism

2.43

1.11

1.4

2.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.01

1.10

2.7

2.2

—

Other pulmonary diagnosis

2.15

1.10

2.7

2.2

—

STROKE

2.48

1.09

2.4

—

Pain in throat and chest

2.12

1.08

2.3

2.5

—

Complications of medical and surgical care

2.14

1.06

2.7

2.2

—

Angina pectoris

2.41

1.06

2.2

2.1

—

Depression

1.89

1.05

2.0

2.4

—

Visual disturbances

2.27

1.03

2.0

2.5

—

Depression or dysthymia

1.94

1.02

2.4

—

Injuries to the head

1.82

1.01

1.6

2.5

—

Injuries to the wrist and hand

1.85

1.00

2.7

2.2

—

Tramadol

2.05

1.00

3.0

2.0

—

Transport accidents

2.22

0.99

1.6

2.2

—

Disorders of gallbladder, biliary tract and pancreas

1.87

0.99

1.4

2.6

—

Anxiety disorders, excluding more controls

1.86

0.99

2.6

2.3

—

Persons encountering health services in other circumstances, wide

1.78

0.98

1.8

2.5

—

Asthma (only as main-diagnosis), excluding more controls

1.99

0.96

2.3

2.2

—

Care involving use of rehabilitation procedures

0.00

0.96

0.0

2.4

—

Tonsillectomy and adenotomy

1.95

0.95

2.3

—

Headache

2.28

0.94

1.3

2.3

—

Excluding asthma or asthma-COPD overlap

1.91

0.88

2.9

2.2

—

COPD differential diagnosis

1.91

0.88

2.9

2.2

—

ILD differential diagnosis

1.91

0.88

2.9

2.2

—

Meniscus derangement

2.05

0.87

3.2

2.0

—

Mood [affective] disorders

1.76

0.87

2.0

2.4

—

Mood disorders

1.76

0.86

2.0

2.4

—

Other heart diseases, wide

1.82

0.86

2.2

2.4

—

Hernia

1.81

0.85

2.6

2.3

—

Any gastric operation

1.82

0.85

3.1

2.2

—

GASTRO-related operations

1.82

0.85

3.1

2.2

—

Antenatal screening

0.00

0.83

0.0

2.4

—

Special screening examination for infectious and parasitic diseases

0.00

0.81

0.0

2.3

—

Benign neoplasm of colon, rectum, anus and anal canal

0.00

0.79

0.0

2.2

—

Obesity

1.80

0.78

2.2

2.3

—

Obesity and other hyperalimentation

1.80

0.78

2.2

2.3

—

Dislocation, sprain and strain of joints and ligaments of knee

1.80

0.77

2.2

2.4

—

Spondylopathies

1.93

0.76

1.6

2.1

—

Dental caries 1, only avohilmo

1.88

0.75

2.6

2.3

—

Dental caries, including avohilmo

1.88

0.75

2.6

2.3

—

Dental caries 1

1.88

0.75

2.6

2.3

—

Abnormalities of breathing

1.67

0.75

1.7

2.3

—

Inguinal hernia

2.11

0.75

3.2

2.3

—

Visual disturbances and blindness

2.08

0.74

2.0

2.4

—

Asthma, unspecified (mode)

2.09

0.74

1.6

2.1

—

Mood disorders, excluding more controls

1.66

0.74

1.9

2.3

—

Asthma, unspecified (mode), excluding more controls

2.07

0.74

1.6

2.1

—

Intracranial injury

2.01

0.73

1.6

3.0

—

Injuries to the elbow and forearm

1.81

0.72

1.6

2.4

—

Abdominal and pelvic pain

1.62

0.72

2.4

—

Low back pain

1.74

0.71

2.7

2.4

—

Ischaemic heart disease, wide definition

1.96

0.70

2.8

2.0

—

Disorders of skin appendages

1.92

0.70

1.2

2.4

—

Any mental disorder

1.67

0.70

2.9

2.3

—

Polyarthropathies

1.73

0.70

2.7

2.3

—

Neurotic, stress-related and somatoform disorders

1.56

0.70

2.6

2.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.90

0.69

2.0

2.1

—

Complications of procedures, not elsewhere classified

1.68

0.68

2.7

2.3

—

Dorsopathies

1.65

0.68

1.8

2.4

—

Mental and behavioural disorders due to psychoactive substance use

1.81

0.67

3.0

2.5

—

Shoulder lesions

1.65

0.67

2.7

2.1

—

Dental caries 3 and operation codes

1.71

0.65

2.5

2.2

—

Leiomyoma of uterus

1.78

0.64

2.4

1.8

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.00

0.62

0.0

1.9

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.00

0.62

0.0

1.9

—

Emergency coronary revascularization (for ACS)

0.00

0.62

0.0

2.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.55

0.60

2.6

2.3

—

Nutritional anaemias

0.00

0.60

0.0

2.6

—

Intracranial trauma

1.79

0.59

1.8

2.5

—

Coxarthrosis, primary

0.00

0.59

0.0

1.9

—

Asthma, hospital admissions , main diagnosis only

1.52

0.59

2.4

2.3

—

Asthma (diagnoses ohter than nonallergic)

1.52

0.58

2.4

2.3

—

Complications of surgical and medical care, not elsewhere classified

1.51

0.58

2.6

2.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1.71

0.57

1.2

2.5

—

Anxiety (asthma-related co-morbidities)

1.69

0.57

2.7

2.3

—

Diseases of oesophagus, stomach and duodenum

1.56

0.56

2.8

2.3

—

Anxiety disorders

1.56

0.56

2.6

2.3

—

Type 2 diabetes, wide definition

1.63

0.55

1.5

2.4

—

Other nutritional deficiencies

1.58

0.54

2.2

2.4

—

Asthma (mode)

1.57

0.53

2.5

2.2

—

Lower back pain or/and sciatica

1.45

0.53

2.8

2.2

—

Symptoms and signs involving the circulatory and respiratory systems

1.57

0.53

1.9

2.3

—

Episodal and paroxysmal disorders

1.52

0.52

2.0

2.4

—

Psychiatric diseases

1.56

0.52

3.1

2.3

—

Injuries to the shoulder and upper arm

1.52

0.52

2.8

2.3

—

Other diseases of intestines

1.53

0.50

2.3

2.4

—

Constipation

1.57

0.49

2.4

2.2

—

Asthma, including avohilmo

1.49

0.49

2.2

2.3

—

Injuries to the ankle and foot

1.48

0.47

2.7

2.2

—

Fall on same level

1.46

0.46

2.2

2.3

—

Ischemic heart diseases

1.65

0.44

2.8

2.2

—

Other arrhythmias

1.59

0.43

1.2

2.4

—

malignant neoplasm of male genital organs

0.00

0.42

0.0

2.5

—

Use of hypnotics and sedatives

1.40

0.42

2.4

2.3

—

Coronary angioplasty

0.00

0.42

0.0

2.2

—

Coronary revascularization (ANGIO or CABG)

0.00

0.42

0.0

2.2

—

Sulfonylureas

0.00

0.42

0.0

2.2

—

Degeneration of macula and posterior pole

0.00

0.41

0.0

1.9

—

Benign neoplasm: Colon

0.00

0.41

0.0

2.5

—

Gastro-oesophageal reflux disease

1.53

0.41

2.0

2.2

—

Diabetes, varying definitions

1.37

0.41

2.3

2.5

—

Rheumatoid arthritis

0.00

0.41

0.0

2.1

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.41

0.0

2.3

—

Iron deficiency anaemia

0.00

0.41

0.0

2.3

—

Schizophrenia or delusion, excluding more controls

0.00

0.41

0.0

2.4

—

Bacterial pneumonia (organism specified)

0.00

0.41

0.0

2.2

—

Kela-code for severe mental illness

0.00

0.41

0.0

2.5

—

Bacterial pneumoniae

0.00

0.41

0.0

2.2

—

Benign neoplasm: Colon

0.00

0.40

0.0

2.1

—

Supervision of high-risk pregnancy

0.00

0.40

0.0

2.7

—

Coxarthrosis, primary, with hip surgery

0.00

0.40

0.0

2.1

—

Bleeding

1.45

0.40

2.6

2.4

—

Other dorsopathies, not elsewhere classified

1.40

0.40

2.0

2.4

—

Benign neoplasm of colon, rectum, anus and anal canal

0.00

0.40

0.0

2.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.35

0.39

1.9

2.5

—

Other antidepressants

1.34

0.38

2.1

2.5

—

Diseases of the skin and subcutaneous tissue

1.43

0.38

1.6

2.5

—

Other diseases of hard tissues of teeth

1.38

0.38

2.6

2.4

—

Asthma

1.53

0.37

2.0

2.2

—

Asthma, excluding more controls

1.52

0.37

2.0

2.2

—

All anxiety disorders

1.46

0.36

2.7

2.2

—

Artificial joint operation, meniscal resection

1.43

0.36

3.0

2.2

—

External causes of morbidity and mortality

1.37

0.35

2.3

2.4

—

Exposure to other specified factors

1.37

0.34

3.3

2.1

—

Dyspnoea

1.31

0.33

1.5

2.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.32

0.31

2.7

2.3

—

Diabetes mellitus

1.33

0.29

2.3

2.4

—

Asthma/COPD (KELA code 203)

1.25

0.27

1.6

2.3

—

Other diseases of upper respiratory tract

1.27

0.26

3.0

2.3

—

Diseases of the ear and mastoid process

0.69

0.25

2.0

2.3

—

Gonarthrosis [arthrosis of knee](FG)

1.34

0.24

3.2

1.8

—

Diseases of the respiratory system

1.32

0.24

3.2

2.2

—

Gonarthrosis,primary

1.31

0.23

3.2

1.9

—

Cardiac arrhythmias

1.27

0.23

1.2

2.5

—

Disorders of lipoprotein metabolism and other lipidaemias

1.26

0.22

1.6

2.4

—

Statin medication

1.22

0.22

2.2

2.4

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

0.00

0.22

0.0

3.3

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.22

0.0

3.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

0.22

0.0

2.3

—

Cholelithiasis

1.21

0.22

1.6

2.4

—

Heart failure and coronary heart disease

0.00

0.22

0.0

2.1

—

Postpartum care and examination

0.00

0.22

0.0

2.3

—

Outcome of delivery

0.00

0.21

0.0

2.5

—

Crowding of teeth, including avohilmo

0.00

0.21

0.0

2.6

—

Perineal laceration during delivery

0.00

0.21

0.0

2.4

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

1.9

—

Abnormal serum enzyme levels

0.00

0.21

0.0

2.5

—

Cholelithiasis, broad definition with cholecystitis

1.18

0.21

1.6

2.4

—

Non-ischemic cardiomyopathy

0.00

0.21

0.0

1.9

—

Hypertensive Heart Disease

0.00

0.21

0.0

2.0

—

Tinnitus

0.00

0.21

0.0

1.5

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.21

0.0

1.8

—

Fibroblastic disorders

0.00

0.21

0.0

1.8

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.8

—

Speech therapy

0.00

0.21

0.0

1.5

—

Symptoms and signs involving speech and voice

0.00

0.21

0.0

1.8

—

Other and unspecified iron deficiency

0.00

0.21

0.0

2.2

—

Parodontitis and operation codes

1.18

0.21

2.2

—

Hypertensive heart and/or renal disease

0.00

0.21

0.0

2.0

—

Dentinal caries

0.00

0.21

0.0

2.8

—

Abrasion of teeth

0.00

0.21

0.0

2.3

—

Malignant neoplasm of prostate

0.00

0.21

0.0

2.7

—

Myocardial infarction, without ST-elevation

0.00

0.21

0.0

2.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

2.2

—

Schizophrenia or delusion

0.00

0.21

0.0

2.6

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.21

0.0

2.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.21

0.0

2.1

—

Bacterial pneumonia, not elsewhere classified

0.00

0.20

0.0

2.1

—

Long labour

0.00

0.20

0.0

2.3

—

General examination and investigation of persons without complaint and reported diagnosis

1.23

0.20

2.2

2.3

—

Retinal detachments and breaks

0.00

0.20

0.0

2.1

—

Rheumatoid arthritis, including avohilmo

0.00

0.20

0.0

1.9

—

Medical observation and evaluation for suspected diseases and conditions

1.18

0.20

3.3

2.3

—

Metabolic disorders

1.16

0.19

1.5

2.5

—

Symptoms and signs involving the digestive system and abdomen

1.25

0.19

2.9

2.4

—

Nerve, nerve root and plexus disorders

1.22

0.18

3.4

2.1

—

Diabetes medication

0.76

0.17

2.0

2.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.17

0.17

2.4

2.3

—

Autoimmune diseases excluding thyroid diseases

1.17

0.17

2.4

2.3

—

Dermatitis and eczema

1.14

0.16

1.9

2.4

—

Dental caries 3, only avohilmo

1.11

0.10

2.8

2.1

—

Dental caries 3

1.11

0.10

2.8

2.1

—

Chronic periodontitis, including avohilmo

1.12

0.10

2.2

—

Parodontitis

1.12

0.10

2.2

—

Parodontitis or operation codes

1.12

0.10

2.2

—

Pain in limb

1.06

0.09

3.4

2.1

—

Polycystic ovarian syndrome, consortium definition

1.13

0.09

2.0

2.3

—

Type 2 diabetes, strict (exclude DM1)

1.12

0.09

1.8

2.3

—

Type 2 diabetes, definitions combined

1.12

0.09

1.8

2.3

—

Type 2 diabetes, definitions combined, including avohilmo

1.11

0.09

1.8

2.3

—

Diseases of the eye and adnexa

1.07

0.09

2.0

2.5

—

Chronic diseases of tonsils and adenoids

1.08

0.09

3.5

2.2

—

Type 2 diabetes

1.08

0.09

1.8

2.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.04

0.08

1.5

2.3

—

Triptan medication for migraine, single purchase ok

1.04

0.08

1.5

2.3

—

Endocrine, nutritional and metabolic diseases

0.77

0.08

2.0

2.4

—

Diabetes, insulin treatment (Kela reimbursement)

0.83

0.08

1.8

2.5

—

Hypothyroidism, other/unspecified

0.80

0.08

2.0

2.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.77

0.08

2.0

2.3

—

Selective serotonin reuptake inhibitors

1.05

0.08

2.4

2.5

—

Used for control exclusion in common control thyroid runs

0.82

0.08

2.3

2.2

—

Autoimmune diseases

1.05

0.07

1.8

2.3

—

Chronic lower respiratory diseases

1.08

0.07

2.0

2.3

—

Alzheimer’s disease (Late onset)

0.00

0.0

2.2

—

Anorexia (incl.atypical)

0.00

0.0

2.8

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.0

1.5

—

Malignant neoplasm of breast, HER-negative

0.00

0.0

2.0

—

Parodontitis, under 40 years and operation codes

0.00

0.0

2.8

—

Fibromyalgia

0.00

0.0

2.0

—

Diseases of salivary glands

0.00

0.0

2.6

—

Calcific aortic valvular stenosis, operated

0.00

0.0

2.0

—

Alzheimer disease, including avohilmo

0.00

0.0

2.3

—

0.00

0.0

2.1

—

Cardiovascular diseases

0.94

0.00

2.4

2.3

—

Otitis media, unspecified

0.00

0.0

2.4

—

Dental pulpitis 4, only avohilmo

0.96

0.00

2.3

—

Impacted maxillary molar

0.00

0.0

3.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.0

3.0

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.0

3.2

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

2.8

—

Calcific aortic valvular stenosis

0.00

0.0

2.0

—

Speech and linguistic disorders

0.00

0.0

2.9

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.6

—

Other and unspecified mood [affective] disorders

0.00

0.0

3.2

—

Eating disorder

0.00

0.0

3.0

—

Unspecified privation

0.00

0.0

2.0

—

Dental pulpitis 4

0.96

0.00

2.3

—

Continuous positive airway pressure

0.00

0.0

2.4

—

Acute and transient psychotic disorders

0.00

0.0

2.2

—

Certain conditions originating in the perinatal period

0.00

0.0

3.1

—

Other menopausal disorders

0.00

0.0

2.2

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.0

1.3

—

Fracture of femur

0.00

0.0

2.1

—

Valvular operations

0.00

0.0

1.4

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.0

2.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.0

2.0

—

Parodontitis, under 40 years

0.00

0.0

2.8

—

Insulin, fast-acting (human)

0.00

0.0

2.7

—

Gastrointestinal diseases

1.00

0.00

2.6

2.5

—

Diseases of pulp and periapical tissues, including avohilmo

0.96

0.00

2.3

—

Scoliosis

0.00

0.0

3.2

—

Diseases of oral cavity, salivary glands and jaws

0.95

0.00

1.8

2.4

—

Crossbite

0.00

0.0

2.8

—

Parodontitis, under 40 years, or operation codes

0.00

0.0

2.8

—

Disorders of tooth development and eruption

0.00

0.0

2.8

—

Dental pulpitis 1

0.96

0.00

2.3

—

Other disorders starting during childhood or adolescence

0.00

0.0

3.2

—

Parodontitis, operation under 40 years and operation codes

0.00

0.0

2.8

—

Specific development disorders of speech and language

0.00

0.0

3.2

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

3.0

—

Alcohol abuse, main dg

0.00

0.0

2.8

—

Acne vulgaris

0.00

0.0

2.9

—

Lichen planus, including avohilmo

0.00

0.0

1.2

—

Cervicalgia

0.00

0.0

2.8

—

Direct fill therapy

0.00

0.0

2.8

—

Other disorders of patella

0.00

0.0

1.8

—

Dental pulpitis 1, only avohilmo

0.96

0.00

2.3

—

L02BA Anti-estrogens

0.00

0.0

1.5

—

Preparation and fitting of bite rail to mouth

0.00

0.0

2.8

—

Budesonide

0.00

0.0

2.0

—

Use of pramipexole

0.00

0.0

1.2

—

Schizophrenia

0.00

0.0

2.2

—

Inguinal or femoral hernia, bilateral

0.00

0.0

1.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.0

2.8

—

Eating disorders

0.00

0.0

2.9

—

Voice disturbances

0.00

0.0

1.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.0

1.3

—

Foreign body on external eye

0.00

0.0

2.8

—

Superficial injury of shoulder and upper arm

0.00

0.0

3.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.6

—

Persistent mood disorders

0.00

0.0

2.0

—

Neurological diseases

0.94

0.00

2.0

2.4

—

Weight loss

0.00

0.0

2.8

—

Contact with other sharp object(s)

0.00

0.0

3.2

—

0.00

0.0

2.8

—

Other special examinations and investigations of persons without complaint or reported diagnosis

0.97

0.00

2.4

2.3

—

Other problems related to primary support group, including family circumstances

0.00

0.0

2.6

—

Personal history of other diseases and conditions

0.00

0.0

3.2

—

Persons encountering health services for specific procedures and health care

0.88

0.00

2.0

2.4

—

Presence of other devices

0.00

0.0

1.8

—

Benign neoplasm: Colon, unspecified

0.00

0.0

2.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.0

1.6

—

Benign neoplasm: Sigmoid colon

0.00

0.0

1.5

—

Specific development disorders of scholastic skills

0.00

0.0

3.2

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.0

1.3

—

Other respiratory disorders and diseases

0.00

0.0

1.6

—

Hypothyroidism, strict autoimmune

1.00

0.00

2.0

2.2

—

Other specific joint derangements/joint disorders

0.88

0.00

3.0

2.2

—

Acute laryngitis and tracheitis

0.00

0.0

3.2

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.0

2.8

—

Accidents

1.00

0.00

2.0

2.4

—

Gingivitis and periodontal diseases

0.96

0.00

2.2

2.4

—

TMD related operations

0.00

0.0

2.8

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

1.3

—

Other and unspecified nonorganic psychotic disorders

0.00

0.0

3.0

—

Finngen Rheumatological endpoints

0.98

0.00

2.2

2.3

—

Seropositive rheumatoid arthritis

0.00

0.0

1.6

—

Benign neoplasm: Rectum

0.00

0.0

1.5

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

0.0

1.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

0.85

0.00

2.0

2.2

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.0

3.2

—

Bitten or struck by other mammals

0.00

0.0

3.0

—

Thoracic aortic aneurysm

0.00

0.0

1.8

—

Aortic aneurysm

0.00

0.0

1.7

—

Disorders of psychological development

0.00

0.0

2.9

—

Congenital malformations of heart and great arteries

0.00

0.0

3.2

—

0.00

0.0

2.1

—

Salpingitis and oophoritis

0.00

0.0

1.6

—

Disorders of the thyroid gland

0.93

0.00

1.8

2.3

—

Palmar fascial fibromatosis [Dupuytren]

0.00

0.0

1.8

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.5

—

Seropositive rheumatoid arthritis, wide

0.00

0.0

1.6

—

Congenital malformations of genital organs

0.00

0.0

3.2

—

Embedded teeth, including avohilmo

0.00

0.0

3.0

—

Gastroduodenal ulcer

0.00

0.0

1.6

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.5

—

Inguinal hernia, bilateral

0.00

0.0

1.6

—

Recurring oral aphthae, including avohilmo

0.00

0.0

2.8

—

severe traumatic brain injury, does not include concussion

0.00

0.0

2.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.93

0.00

2.4

—

Alzheimer’s disease, wide definition

0.00

0.0

2.3

—

Endometriosis of ovary

0.00

0.0

2.7

—

Other soft tissue disorders, not elsewhere classified

0.98

0.00

3.0

2.1

—

Any event in cancer register

0.96

0.00

1.8

2.5

—

Other diseases of the respiratory system

0.00

0.0

1.6

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.0

1.3

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.0

—

Acne

0.00

0.0

3.0

—

Endometriosis ASRM stages 3,4

0.00

0.0

1.9

—

Acute appendicitis, with complications

0.00

0.0

1.8

—

Viral warts

0.00

0.0

3.2

—

Wet age-related macular degeneration

0.00

0.0

2.2

—

Antihypertensive medication - note that there are other indications

0.94

0.00

2.0

2.3

—

Soft tissue disorders

0.96

0.00

2.4

2.1

—

Primary open-angle glaucoma, strict

0.00

0.0

2.0

—

Hypothyroidism, drug reimbursement

0.00

0.0

1.9

—

Myopia

0.00

0.0

3.0

—

Other hammer toe(s) (acquired)

0.00

0.0

1.7

—

Use of memantine

0.00

0.0

2.3

—

Deep bite

0.00

0.0

2.8

—

Mycoses

0.00

0.0

1.8

—

Non-invasive ventilation

0.00

0.0

2.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.0

2.6

—

Cutaneous abscess, furuncle and carbuncle

0.00

0.0

2.7

—

Use of donepezil

0.00

0.0

2.2

—

Gastric ulcer

0.00

0.0

1.6

—

Chronic laryngitis and laryngotracheitis

0.00

0.0

1.6

—

Use of other anti-dementia drugs

0.00

0.0

2.3

—

Other eating disorders

0.00

0.0

3.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.0

2.6

—

Psoriasis vulgaris

0.00

0.0

2.0

—

Coronary artery bypass grafting

0.00

0.0

2.3

—

Congenital malformations of the circulatory system

0.00

0.0

3.2

—

Alzheimer disease

0.00

0.0

2.3

—

Lateral epicondylitis

0.00

0.0

1.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.93

0.00

1.8

2.5

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.0

1.2

—

Seronegative rheumatoid arthritis

0.00

0.0

1.2

—

Operations 2 for CAVS

0.00

0.0

2.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Plasmodium malariae Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS